Piper Jaffray Downgrades Questcor Pharmaceuticals (QCOR) to Neutral
Tweet
Share
E-mailGet Alerts QCOR Hot Sheet
Price: $93.60 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Join SI Premium – FREE
Piper Jaffray downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Overweight to Neutral following a U.S. probe into marketing practices. The firm's price target was cut from $67 to $43.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals are down 31.6 percent to $20.60.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals are down 31.6 percent to $20.60.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades ULTA Salon (ULTA) to Hold, 'Competition Intensifying & Prestige Refresh Needed'
- Piper Sandler Downgrades Magnolia Oil & Gas Corp. (MGY) to Neutral
- Canaccord Genuity Downgrades Netflix (NFLX) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
